Cannabis use among recently treated cancer patients: perceptions and experiences

Supportive Care in Cancer, Journal Year: 2023, Volume and Issue: 31(9)

Published: Aug. 31, 2023

Language: Английский

---

Barriers and facilitators to prescribing medicinal cannabis in New Zealand

Journal of Primary Health Care, Journal Year: 2023, Volume and Issue: 15(2), P. 135 - 146

Published: March 2, 2023

Introduction The New Zealand Medicinal Cannabis Scheme (NZMCS) was established in April 2020 with the aim of expanding access to quality controlled medicinal cannabis products and developing a domestic industry. Yet, two years later, many patients report challenges utilising NZMCS, including physicians' reluctance provide prescriptions for products. Aim To explore barriers facilitators prescribing Zealand. Methods We conducted semi-structured interviews 31 physicians (general practitioners, specialists, clinicians) who had discussed last 6 months. Results Physicians reported principal barrier limited clinical evidence support therapy. Further included: perceived lack knowledge cannabis; concerns over professional reputation; social stigma; price Conversely, factors that facilitated included patients' some desire avoid having engage private clinics; timing prescription requests (ie considering after other treatments been exhausted). Discussion research medications, education training, information would deliver more informed advice enhance confidence therapies.

Language: Английский

---

Reducing medical cannabis use risk among Veterans: A descriptive study

Harm Reduction Journal, Journal Year: 2025, Volume and Issue: 22(1)

Published: Jan. 15, 2025

Canadian Veterans experiencing chronic pain report concerns about accessing accurate information on the risks associated with medical cannabis (MC) use. The Lower Risk Cannabis Use Guidelines (LRCUG) were developed to equip individuals who use recreationally safer-use strategies. Many of harm reduction recommendations for recreational are relevant and important considerations MC primary objective our study was assess Veterans' awareness interest in LRCUG, engagement potential higher-risk behaviours. Armed Forces living (N = 582) recruited online through Chronic Pain Centre Excellence Veterans. Participants completed measures on: (never, past, current use), sources knowledge, mental health, receiving LRCUG. Chi-Square post-hoc analyses characterized sample assessed demographic differences based status Engagement behaviours aligned LRCUG recommendations, detailed descriptively. currently more likely be unemployed (z 3.62, p < .01), released as a Non-Commissioned Officer -3.83, unable work due disability -3.43, .01) than do not Less 30% aware greater among (n 356). that contradicted ranged from ~ 9% 85%. Approximately experienced co-morbid health concerns, yet their purposes (LRCUG recommendation #7). Additionally, almost 85% engaged daily #5). majority two or (60.2%; #12). Almost half all received healthcare provider internet. Our suggests importance safer guidelines tailored Development lower-risk can support prescribing practitioners needed better-informed decisions, patients' needs circumstances.

Language: Английский

---

Healthcare Professionals’ Perceptions About Medical Cannabis in Greece: A Qualitative Study

Journal of Market Access & Health Policy, Journal Year: 2025, Volume and Issue: 13(2), P. 13 - 13

Published: April 2, 2025

Background: Medical cannabis continues to generate interest as a potential therapeutic option, yet its acceptance in clinical practice faces challenges, including regulatory barriers, social stigma, and gaps scientific evidence. Methods: This study explores the perspectives of Greek medical doctors pharmacists on cannabis—key stakeholders application—through semi-structured interviews with 12 participants from each profession. Results: expressed range views cannabis, many acknowledging while emphasizing need for rigorous, disease-specific research. highlighted lack consistent trials, concerns about drug interactions, fine line between use misuse. Pharmacists echoed these concerns, citing inconsistencies standardized dosing. Both groups agreed that stigma misinformation hinder adoption, advocating targeted education transparent research communication. Participants indicated barriers also pose calls harmonized policies phased market entry approaches. Effective communication strategies, digital outreach clear messaging, were suggested differentiate recreational improve trust among healthcare providers patients. urgent collaboration policymakers, researchers, professionals establish credible option. Conclusion: The insights gained provide actionable recommendations bridge existing emphasize responsible, evidence-based approach

Language: Английский

---

Assessing the Market Readiness for Medical Cannabis in Greece: A Qualitative Study of Patient Perspectives

Medicines, Journal Year: 2025, Volume and Issue: 12(2), P. 12 - 12

Published: May 9, 2025

Background: The introduction of medical cannabis in Greece marks a shift healthcare policy, yet patient attitudes remain underexplored. Methods: This qualitative study examines the market readiness for through semi-structured interviews with 24 participants-12 users cannabidiol (CBD)-based formulations and 12 cannabis-naive individuals. Results: CBD-experienced patients generally perceive cannabis-based treatments as beneficial managing musculoskeletal pain, migraines, anxiety, stress sleep disturbances, despite concerns over product quality, cost limited guidance. Medical participants express skepticism due to stigma perceived insufficient evidence but acknowledge potential therapeutic value within regulated framework. highlights need better education, physician training clear regulatory guidelines support responsible entry. Conclusions: These findings offer important insights policymakers, providers pharmaceutical industry, emphasizing structured, evidence-based approach integration Greece. Further research is needed assess long-term experiences evolving impact changes on dynamics.

Language: Английский

---

Medicinal Cannabis Guidance and Resources for Health Professionals to Inform Clinical Decision Making

Clinical Therapeutics, Journal Year: 2023, Volume and Issue: 45(6), P. 527 - 534

Published: June 1, 2023

Language: Английский

---

Planting the seeds for success: A qualitative study exploring primary healthcare providers’ perceptions about medical cannabis

PLoS ONE, Journal Year: 2024, Volume and Issue: 19(3), P. e0295858 - e0295858

Published: March 7, 2024

Background In Canada, cannabis legalization altered the way that public can access for medical purposes. However, Canadians still struggle with finding healthcare professionals (HCPs) who are involved in counselling and authorization. This raises questions about barriers causing this breakdown care. Our study explored perceptions of primary care providers regarding their practice. Methods Semi-structured interviews were conducted by Zoom HCPs Newfoundland Labrador (NL) to discuss experiences non-medical Family physicians nurse practitioners practicing NL included. The interview guide coding template developed using Theoretical Domains Framework (TDF). A thematic analysis across TDF was then conducted. Results Twelve participants diverse demographic backgrounds experience levels interviewed. Five main themes emerged including, knowledge acquisition, internal influences, patient external HCP systemic influences. domain resulting greatest representation codes environmental context resources. Interpretation findings suggested have significant gaps authorizing cannabis, which limited practice competence confidence area. Referring patients clinics, while enforcing harm-reduction strategies, an interim option developing guidelines educational resources as prominent facilitators promote authorization within system.

Language: Английский

---

Knowledge and perceptions about Cannabidiol use

Journal of Drug Delivery and Therapeutics, Journal Year: 2024, Volume and Issue: 14(1), P. 113 - 120

Published: Jan. 15, 2024

Background: Cannabidiol (CBD) is one of the main cannabinoids present in cannabis plant. The demand for CBD grew over time with more individuals consuming products due to its potential therapeutic properties. Objectives: To assess knowledge and perceptions Maltese members public health care professionals (HCPs) about CBD, Methods: Surveys aiming perception HCPs were developed, validated disseminated. Results: Four hundred 150 completed questionnaires. Ninety-six percent participants (n=384) agreed that has a effect. Respondents from general mostly knowledgeable use, had positive relation like HCPs, feel comfortable if recommended by HCPs. not so certain aspects on CBD. One twelve aware there only FDA/EMA approved CBD-based product. would prescribing pain insomnia majority them (55%; n=83) believe an analgesic Social stigma associated use judgement barriers use. Conclusion: Increased research, availability information guidelines related might lead increased willingness recommend decrease use. Keywords: Cannabidiol, perceptions,

Language: Английский

---

Canada’s Recreational Cannabis Legalization and Medical Cannabis Patient Activity, 2017–2022

American Journal of Public Health, Journal Year: 2024, Volume and Issue: unknown, P. e1 - e8

Published: Oct. 3, 2024

To estimate changes in medical cannabis patient activity after Canada's recreational legalization.

Language: Английский

---

Evidence synthesis of medical cannabis research: current challenges and opportunities

European Archives of Psychiatry and Clinical Neuroscience, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 9, 2024

Abstract As a wide group of medicines, the effectiveness and safety ‘medical cannabis’ products is likely to vary in relation product-specific dimensions such as potency, dosage, route administration, cannabinoid composition. Systematic reviews can perform crucial role analysing synthesising outcomes medical cannabis interventions found empirical research. We analysed 23 contemporary systematic on discern extent which this body work aimed capture, ultimately captured, differing by treatment. further highlighted methodological reasons given authors for an inability describe granular level information. that minority explicitly subgroup analysis determine differences treatment cannabis, with even fewer subsequently doing so. Authors’ stated concerned either overly large or small levels variation characteristics, compositions, administrations used, rendering analyses methodologically inappropriate inapplicable. Furthering reviews’ abilities capture information treatments will require standardisation studies.

Language: Английский

---